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Abstract
Sleep and sleep intensity are enhanced by adenosine and its receptor agonists, while adenosine
receptor antagonists induce wakefulness. Adenosine kinase (ADK) is the primary enzyme
metabolizing adenosine in adult brain. To investigate whether adenosine metabolism or clearance
affects sleep we recorded sleep in mice with engineered mutations in Adk. Adk-tg mice over-
express a transgene encoding the cytoplasmic isoform of ADK in the brain, but lack the nuclear
isoform of the enzyme. Wild-type mice and Adk+/− mice that have a 50% reduction of the
cytoplasmic and the nuclear isoforms of ADK served as controls.
Adk-tg mice showed a remarkable reduction of EEG power in low frequencies in all vigilance
states and in theta activity (6.25–11 Hz) in REM sleep and waking. Adk-tg mice were awake 58
min more per day than wild-type mice and spent significantly less time in REM sleep (102±3 vs
128±3 min in wild-type). After sleep deprivation slow-wave activity (0.75–4 Hz), the intensity
component of NREM sleep, increased significantly less in Adk-tg mice and their slow-wave
energy was reduced. In contrast, the vigilance states and EEG spectra of Adk+/− and wild-type
mice did not differ. Our data suggest that over-expression of the cytoplasmic isoform of ADK is
sufficient to alter sleep physiology. ADK might orchestrate neurotransmitter pathways involved in
the generation of EEG oscillations and regulation of sleep.
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Introduction
The neuromodulator adenosine plays a key role in sleep regulation (Radulovacki, 1985;
Benington and Heller, 1995; Basheer et al., 2004; Datta and Maclean, 2007; Huang et al.,
2007; Scharf et al., 2008). Adenosine and adenosine receptor agonists enhance NREM and
REM sleep (Marley and Nistico, 1972; Haulica et al., 1973; Snyder et al., 1981; Virus et al.,
1983; Radulovacki et al., 1985; Sarda et al., 1986; Martin et al., 1989; Ticho and
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Radulovacki, 1991; Portas et al., 1997). Moreover, the adenosine agonist
cyclopentyladenosine enhanced EEG slow-wave activity (SWA; power between 0.75–4 Hz;
Benington et al., 1995; Schwierin et al., 1996). Adenosine receptor antagonists (caffeine,
cyclopentyltheophylline) induce wakefulness (Yanik et al., 1987; Biaggioni et al., 1991;
Landolt et al., 1995; Schwierin et al., 1996; Huang et al., 2005). The effects of adenosine on
sleep are mediated by adenosine A1 (Basheer et al., 2001; Thakkar et al., 2003; Alanko et
al., 2004; Bjorness et al., 2009) and A2A receptors (Hayaishi et al., 2004). Inhibition of
gliotransmission attenuated the accumulation of sleep pressure through A1 receptors
(Halassa et al., 2009).
Despite its ubiquitous presence, some studies indicated a role of adenosine in sleep in
specific brain regions. The basal forebrain was suggested to gate sleep via adenosinergic
inhibition of wake-promoting cholinergic neurons (Porkka-Heiskanen et al., 1997; Porkka-
Heiskanen et al., 2000; Strecker et al., 2000). However, stimulation of adenosine receptors
in other regions (e.g. hypothalamus) also induced sleep (Satoh et al., 1998; Satoh et al.,
1999; Scammell et al., 2001; Gallopin et al., 2005; Methippara et al., 2005; Oishi et al.,
2008).
A little explored avenue in sleep is the in vivo manipulation of adenosine kinase (ADK), the
primary enzyme regulating adenosine metabolism in rodents (Mathews et al., 1998; Boison,
2006). Inhibition of ADK activity induced a larger adenosine increase in hippocampal and
cortical slices than adenosine deaminase inhibition (Pak et al., 1994; Lloyd and Fredholm,
1995; White, 1996). Moreover, adenosine release was higher in ADK-deficient fibroblasts
compared to adenosine deaminase-deficient fibroblasts (Huber et al., 2001). Sleep
deprivation (SD) had no effect on ADK activity in the cortex and basal forebrain, but the
diurnal variation of ADK activity (Chagoya de Sanchez et al., 1993; Alanko et al., 2003)
was maximal in the cortex (Mackiewicz et al., 2003).
Here we used mice constitutively over-expressing a transgene for the cytoplasmic isoform of
Adk (Adk-tg). These mutants are characterized by increased ADK enzyme activity and
reduced adenosine tone in the brain (Fedele et al., 2005). Based on the reduced adenosine
tone, mutants display spontaneous intrahippocampal seizures (Li et al., 2007; Li et al.,
2008a; Li et al., 2008b), increased susceptibility to stroke or seizure-induced neuronal cell
death (Pignataro et al., 2007) and cognitive impairment (Yee et al., 2007). We hypothesized
that the transgene over-expression in Adk-tg mice should affect sleep. As controls we chose
Adk+/− mice, which have reduced ADK in the liver, but normal adenosine metabolites
(Boison et al., 2002) and wild-type (WT) littermates. The mice were subjected to 6-h SD to
stimulate sleep regulatory mechanisms.
Materials and methods
Animals
Adult heterozygous male mice originating from a targeted disruption of the Adk-gene
(Adk+/−), maintained on a mixed 129/JEms × C57Bl/6 background (see Boison et al., 2002
for characterization), and wild-type (WT) littermates were obtained by heterozygous
breeding (n = 15 Adk+/−, n = 14 WT mice). Mice over-expressing the cytoplasmic isoform
of ADK were derived by rescuing the lethal phenotype of Adk−/− mice by introducing a
UbiAdk transgene into the Adk−/− background (Fedele et al., 2005) and maintained by
homozygous breeding of Adk-tg mice (n = 11). The mice were kept individually in Macrolon
cages (36 × 20 × 35 cm) with food and water available ad libitum, maintained on a 12 h light
- 12 h dark cycle (~ 30 lux; light onset at 8:00) at 23°C ambient temperature. The Cantonal
Veterinary Office of Zurich approved all experimental procedures.
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Surgery: EEG/EMG electrode implantation
Mice were implanted epidurally with gold-plated miniature screws (0.9 mm diameter) for
EEG recording under isoflurane anesthesia (right hemisphere: above the frontal (FRO), 1.5
mm anterior to bregma, 2 mm lateral to the midline, and the parietal cortex (PAR), 2 mm
posterior to bregma, 3 mm lateral to midline; reference: above the cerebellum, 2 mm
posterior to lambda, on the midline). Two gold wires (0.2 mm diameter) were inserted
bilaterally into the neck muscles for electromyogram (EMG) recording. The electrodes were
connected to stainless steel wires fixed to the skull with dental acrylic cement. The mice
were connected by a fine cable to a swivel, and remained connected throughout the
experiment. At least 3 weeks were allotted for recovery from surgery and a minimum of 3
days for habituation to the recording chambers before data collection.
Experimental protocols
Recordings were performed during a 24-h baseline followed by 6 h SD starting at light onset
and 18 h recovery. SD was performed by directly observing the mice and introducing new
material into the cage (e.g. nesting material, wood or cardboard pieces) whenever a mouse
appeared to be drowsy. If necessary, acoustic stimulation was used by gentle tapping on the
cage (Tobler et al., 1997). Special care was taken not to interfere with eating and drinking
behavior. Data were collected from frontal and parietal EEG derivations, because slow
waves and spindles in NREM sleep are more prominent in the frontal EEG, whereas theta
activity in waking and REM sleep is prominent in the parietal EEG.
A separate batch of Adk-tg (n = 12) and WT mice (n = 11) were placed in single cages
equipped with an infra-red sensor mounted above the cage for undisturbed, continuous
motor activity recordings for 10 consecutive days (Chronobiology Kit, Stanford Software
Systems, Stanford, CA).
Data acquisition and analysis
The EEG and EMG signals were amplified (amplification factor approx. 2000), conditioned
by analogue filters (high-pass filter: −3 dB at 0.016 Hz; low-pass filter: −3 dB at 40 Hz, less
than −35 dB at 128 Hz) sampled with 512 Hz, digitally filtered (EEG: low-pass FIR filter 25
Hz; EMG: band-pass FIR filter 20–50 Hz) and stored with a resolution of 128 Hz. The EEG
power spectra were computed for 4-s epochs by a Fast Fourier Transform (FFT) routine.
Adjacent 0.25-Hz bins were averaged into 0.5-Hz (0.25–5 Hz) and 1.0-Hz (5.25–25 Hz)
bins. The EMG was full-wave rectified and integrated over 4-s epochs; ambient temperature
within the animal cage was sampled at 4-s intervals. Before each recording the EEG and
EMG channels were calibrated with a 10-Hz, 300 μV peak-to-peak sine wave.
The three vigilance states NREM sleep, REM sleep and waking were determined off-line by
visual inspection of the parietal and frontal EEG, EMG records and EEG power in the slow-
wave range (0.75–4 Hz) for 4-s epochs. Epochs containing EEG artifacts in one derivation
were excluded from spectral analyses of both EEG derivations (6.3 ± 0.6 % of recording
time, which occurred mainly during active waking). Vigilance states could always be
determined. The frequency and duration of vigilance state episodes was computed using the
methods of Deboer et al. (1994). Sleep continuity was assessed by determining the number
of brief awakenings (episodes of waking <16 sec, Deboer et al., 1994). The time course of
slow-wave activity (SWA; 0.75–4 Hz), spindle frequency activity (SFA; 10.25–15 Hz) and
theta activity (6.25–9 Hz) for 2 min before and after the transition from waking or REM
sleep to NREM sleep or from NREM sleep to REM sleep was computed as previously
(Franken et al., 1994). Data analysis was performed using the MATLAB software package
(The Math Works, Inc., Natick, MA, USA).
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Western blot analysis
We determined protein levels of ADK in brains of Adk-tg, Adk+/− and WT mice which had
been used for sleep recordings (n=6 mice per genotype). Brain tissue from the right
hemispheres was processed for aqueous protein extracts as previously described (Gouder et
al., 2004). Cell extracts were resuspended, each containing 40 μg proteins, and
electrophoresed in a 10% Tris-glycine gel. After blotting, the membranes were incubated
with polyclonal rabbit antiserum against ADK (1:5,000) and processed as described (Gouder
et al., 2004). The membranes were then developed by incubation with peroxidase-
conjugated anti-rabbit antibody (#7074, 1:8,000, Cell Signaling, Danvers, MA).
Immunoblots were quantified using a Kodak Scientific Imaging System (v3.6.5.k2, Kodak).
To normalize ADK immunoreactivity, a mouse monoclonal anti-α-Tubulin antibody (#
sc-8035, 1:5,000; Santa Cruz, CA) was reprobed on the same blot and the OD ratio of ADK/
α-Tubulin was calculated.
Statistical analysis
Genotype differences were evaluated by linear mixed model analysis of variance (ANOVA),
corrected for multiple comparison when appropriate, or by a repeated measures ANOVA
(SAS software, SAS Institute, Cary, NC, USA). Post-hoc paired and unpaired t-test or
Tukey-Kramer, Bonferroni and Kruskal-Wallis tests were performed if the results of the
ANOVA reached statistical significance (p < 0.05). All reported values are means over 6 –
15 mice ± SEM.
Results
Over-expression of Adk affects the EEG and impairs sleep regulation
We previously demonstrated reduced adenosinergic tone in Adk-tg mice (Fedele et al., 2005)
that was subsequently validated in several experimental paradigms (Li et al., 2007;
Pignataro et al., 2007; Yee et al., 2007; Li et al., 2008a; Li et al., 2008b). We therefore
hypothesized that this genetic modification would affect sleep.
EEG power spectra—A statistically significant reduction of EEG power density was
observed in the frequencies below 4 Hz in all vigilance states in Adk-tg mice compared to
WT mice (Figs. 1 and 2). In addition, in REM sleep and waking, EEG power was
significantly lower in the Adk-tg mice in the frequencies encompassing the theta band (6.25–
11 Hz; Fig. 1).
Baseline sleep—Adk-tg mice slept approximately 60 min less than WT mice in the dark
period (Table 1; Fig. 3 left). The duration of their waking and NREM sleep episodes was
significantly longer than in WT mice, while their total episode number was lower, indicating
more consolidated sleep in Adk-tg mice (Table 2). The relative number of longer NREM
sleep episodes (>128 sec) was higher in Adk-tg mice compared to WT mice at the cost of
shorter (36–64 sec) episodes (Fig. 4 left; p < 0.005, Tukey-Kramer test). Sleep
fragmentation (defined as the occurrence of waking episodes <16 sec per hour of sleep),
differed between the genotypes (Adk-tg, 20.1 ± 1.3; WT, 24.7 ± 1.5; p = 0.039, unpaired t-
test).
The amount of REM sleep as well as REM sleep per total sleep time was reduced in Adk-tg
mice (Table 1; Fig. 3 left), due to a decreased REM sleep episode frequency (Table 2, p =
0.0041, unpaired t-test).
Motor activity data obtained in a separate group of Adk-tg and WT mice corroborated the
sleep findings. Adk-tg mice spent more time active in the dark period (12-h dark: 328.8 ±
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11.3 vs 268.5 ± 9.1 min, p = 0.0017, unpaired t-test). The intensity of their movements
(activity counts per minute) was also significantly higher compared to WT mice (Fig. 4).
In summary, during baseline, sleep and EEG power in frequencies encompassing SWA in
NREM sleep and theta activity in waking and REM sleep were reduced in Adk-tg mice.
Effects of enhanced sleep pressure by 6 h SD—During recovery after SD, Adk-tg
and WT mice showed the typical compensatory increase of NREM sleep with a concomitant
reduction in waking (Table 1; Fig. 3). However, the NREM sleep increase was significantly
larger in the Adk-tg mice in hours 7–12 (Table 1). The REM sleep rebound was delayed to
the second 6-h recovery interval in all mice (Table 1). Although the baseline genotype
differences in REM sleep persisted during recovery (Fig. 3), the response to SD was similar
in Adk-tg and WT mice (recovery-baseline, 6-h intervals 1 – 3: −1.9 ± 1.2 vs −1.5 ± 1.1 min,
p = 0.81; 8.9 ± 1.5 vs 9.2 ± 1.4 min, p = 0.88; 1.8 ± 1.5 vs 3.2 ± 2.0 min, p = 0.56, unpaired
t-test, in WT vs Adk-tg mice, respectively).
SWA and slow wave energy—We hypothesized that following SD, mice over-
expressing ADK would display a reduced increase in SWA. Accordingly, sleep intensity
was significantly lower in Adk-tg mice compared to WT mice (Fig. 5A). The magnitude of
the typical SD-induced initial increase in SWA was not only lower by 9–12 % in Adk-tg
mice (first 2-h interval: p < 0.01, unpaired t-test, for PAR and FRO EEG), but SWA
remained lower in Adk-tg mice throughout the entire recovery period in both EEG
derivations (Fig. 5A). While baseline levels were attained by all mice after 4–6 h recovery,
only Adk-tg mice showed a subsequent negative rebound below baseline. The genotype
SWA difference in NREM sleep was also evident at the transitions from waking to NREM
sleep during the first 6-h recovery interval (Fig. 5B). The increase (i.e. build-up) of SWA in
Adk-tg mice was significantly lower compared to WT mice immediately after the transitions
and remained below the WT increase throughout the 2-min NREM sleep episodes. During
the corresponding baseline interval, the dynamics of SWA build-up had been similar in the
two genotypes (Fig. 5B). All genotype differences dissipated in the second 6-h recovery
interval.
We computed slow-wave energy (SWE; 0.75–4 Hz) which takes into account the difference
in the amount of NREM sleep between genotypes. Despite the larger amount of NREM
sleep, Adk-tg mice reached a significantly lower SWE level after 18-h recovery compared to
WT mice in the parietal EEG (82.1 ± 1.3 % vs 87.5 ± 1.8 %; p = 0.034, unpaired t-test).
Significance was not attained in the frontal EEG due to larger inter-individual variability
(82.2 ± 1.9 vs 87.9 ± 2.2 %; p = 0.072).
Spindle frequency activity (SFA)—Slow waves and spindles are EEG hallmarks of
NREM sleep, the latter being most prominent at the transition from NREM sleep to REM
sleep (Franken et al., 1994; Vyazovskiy et al., 2004). Spindle density and SWA in NREM
sleep show inter-related dynamics in rats and humans (Aeschbach et al., 1997; Vyazovskiy
et al., 2004). In addition to the reduced levels of SWA attained by Adk-tg mice, the typical
surge of SFA immediately before the NREM-REM sleep transitions was significantly
reduced in Adk-tg mice during baseline (Fig. 6) and recovery (not shown) compared to WT
mice.
Overall, Adk-tg mice showed a reduced homeostatic response to enhanced sleep pressure
compared to WT mice.
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Theta peak frequency in REM sleep was lower in Adk-tg mice
Oscillations in the theta frequency range are a distinct feature of REM sleep in rodents (Figs.
1 and 2; Huber et al., 2000). REM sleep EEG spectra were significantly lower in the theta
frequency range in Adk-tg mice compared to WT mice. Based on the significant bins in Fig.
1 (7.25–11 Hz) we investigated whether EEG power would be affected at the transitions
from NREM to REM sleep. Adk-tg mice lacked the typical, prominent increase in theta
activity after the transitions to REM sleep (Fig. 6). Their theta activity levels were
significantly lower than those of WT mice 20 s before the transitions, and remained at a
consistently low level after the transitions to REM sleep (the result was similar when the
time course of the traditional theta frequency band, 6.25–9 Hz, was computed).
Adenosine is directly linked to energy metabolism in the cell (Scharf et al., 2008) and the
peak frequency of theta in REM sleep was affected by a deficiency in energy metabolism
(Tafti et al., 2003). We determined the peak frequency within the theta frequency band for
individual mice. In Adk-tg mice the peak was at a significantly lower frequency than in WT
mice (7 ± 0.1 Hz vs 8 ± 0.1 Hz, p < 0.0001, unpaired t-test).
Effects of Adk over-expression on EEG power during induced wakefulness
To investigate whether the genotype differences in the response to SD were due to
behavioral differences during SD, we analyzed the corresponding EEG spectra (Fig. 7). The
typical increase in EEG power in the course of SD was observed for a large frequency range
(0.75–8 Hz) in both genotypes and in higher frequencies (13–15 Hz; p < 0.05, paired t-test)
in Adk-tg mice. The rise rate of EEG power (interval 3 as % of interval 1) differed between
the two genotypes in frequencies within the SWA band, theta activity and SFA (Fig. 7). The
increase in the 2.25–3.5 Hz band was apparent in all mice (interval 1 vs 3: p < 0.0005), but
the rise rate was significantly lower in the Adk-tg mice (p = 0.0487, Kruskal-Wallis test).
Theta activity was significantly higher in Adk-tg mice than in WT mice throughout SD (rise
rate, p = 0.0004, unpaired t-test). SFA increased in the course of SD in Adk-tg mice only (p
= 0.044, paired t-test), but was significantly lower during the first two 2-h intervals
compared to WT mice (rise rate, p = 0.0455, unpaired t-test).
Reduced expression of Adk has no major effect on sleep
Our prior data suggest that adenosine metabolism is not significantly altered in Adk+/− mice
(normal AMP, ADP, ATP, SAM, SAH levels and normal physiology; Boison et al., 2002).
We therefore hypothesized that sleep would not be altered under conditions of reduced
ADK, but normal adenosine metabolites. The amount of sleep (Table 1; Fig. 8), as well as
the average duration and frequency of vigilance state episodes (data not shown), did not
differ between Adk+/− and WT mice. Moreover, the 24-h baseline time course of SWA in
NREM sleep was similar in the two genotypes (Fig. 8). When sleep pressure was enhanced
by SD, the typical increase in NREM sleep, REM sleep and SWA in NREM sleep was
evident, but none of these variables differed significantly between Adk+/− and WT mice
(Table 1). We conclude that the changes in ADK expression per se in the absence of any
changes in adenosine metabolites do not affect sleep.
ADK protein expression level
To validate our findings, we retrospectively quantified ADK protein expression levels in
brain extracts from representative experimental animals of each genotype after conclusion of
the experiments (n=6 per genotype). Adk-tg mutants expressed significantly higher ADK
levels in the brain (142 % vs. WT mice, p < 0.001, unpaired t-test) of the short ADK isoform
(Fig. 9), while ADK expression levels of the short and long ADK isoforms in Adk+/− mice
were significantly lower (65 % of WT mice, p < 0.001, unpaired t-test).
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Discussion
Adenosine levels in adult brain are largely regulated by an astrocyte-based adenosine cycle
(Boison, 2008). Astrocytes can release adenosine precursor ATP either by vesicular
transport (Pascual et al., 2005) or via hemichannels (Kang et al., 2008). Once outside the
cell ATP is rapidly degraded by a cascade of ectonucleotidases (Zimmermann, 2000). In
contrast to conventional neurotransmitters, there is no regulated transporter-mediated
reuptake system for adenosine. On the contrary, astrocytes express two types of equilibrative
nucleoside transporters (Baldwin et al., 2004). Inside the cell adenosine is removed by
phosphorylation into AMP by ADK. Thus, ADK drives the influx of adenosine into the
astrocytes and regulates the abundance of extracellular adenosine.
Role of ADK in sleep homeostasis
In this study we show for the first time that increasing ADK, the key enzyme controlling
adenosine levels, robustly altered vigilance states and specific EEG oscillations which are
the hallmarks of NREM sleep, REM sleep and wakefulness. In particular, the increases in
brain ADK protein and ADK activity in Adk-tg mice resulted in a remarkable reduction of
EEG power below 4 Hz and in the theta frequency range (Fig. 1), pointing to a deficiency in
mechanisms generating EEG slow waves and theta oscillations. Moreover, ADK over-
expression led to a reduction of sleep, which was partially compensated for by an increase in
sleep consolidation. Under enhanced sleep pressure a deficiency in the homeostatic
regulation of sleep became apparent in Adk-tg mice. The increase of SWA in NREM sleep
and its build-up at the waking-NREM sleep transitions were lower in Adk-tg mice (Fig. 5),
indicating a reduced capacity to intensify sleep. This finding is remarkable since Adk-tg
mice had slept less than WT mice during the dark period preceding SD. Therefore, they
were under higher sleep pressure at the beginning of SD. The deficiency in sleep regulatory
mechanisms was further demonstrated by the lower SWE accumulated after 18 h recovery in
Adk-tg mice.
ADK is highly conserved in evolution and ubiquitously expressed (Boison, 2006). Its
importance for survival is emphasized by the lethality of the disruption of the Adk gene
(Boison et al., 2002). Two different isoforms of ADK exist (Cui et al., 2009), a cytoplasmic
isoform thought to regulate ambient levels of adenosine, while a nuclear isoform might be
implicated in epigenetic mechanisms. This dual functionality of the enzyme has been
postulated previously (Studer et al., 2006). Heterozygous Adk mice have no obvious
phenotype (Boison et al., 2002), which we here confirmed for sleep and sleep regulation.
We reported earlier that Adk+/− mice display alterations in ADK expression in the absence
of changes in adenosine metabolism. These findings suggest that the nuclear isoform of
ADK is likely not involved in sleep regulation. In line with this notion, Adk-tg mice that
selectively over-express the cytoplasmic isoform of ADK, but lack the nuclear isoform of
ADK show a profound sleep phenotype. Together these data suggest that the cytoplasmic,
but not the nuclear isoform of ADK is involved in sleep regulation.
Sleep deprivation enhanced extracellular adenosine which thereafter decreased during
recovery sleep (Porkka-Heiskanen et al., 1997; Porkka-Heiskanen et al., 2000; Basheer et
al., 2004). Benington and Heller (1995) proposed that adenosine continues to be released
during recovery from SD as a product of a putative restorative process occurring during
sleep. The astrocytic and neuronal ADK over-expression in Adk-tg mice should lead to a
faster adenosine clearance from the extracellular space resulting in a slower accumulation of
sleep need during prolonged wakefulness, and in a reduced response to SD. Thus, we had
hypothesized that the overall reduction in brain adenosine levels in Adk-tg mice might not
only modify sleep under baseline conditions but also attenuate the rise in sleep pressure
during SD, and impair sleep restorative processes during recovery.
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The deficiency in the Adk-tg mice was not restricted to EEG slow waves, but also comprised
spindle activity in NREM sleep and theta activity in waking and REM sleep. Spindle and
slow-wave oscillations originate in the thalamocortical network and depend on the
hyperpolarization of thalamocortical neurons (Steriade et al., 1993). Notably, Adk-tg mice
showed both reduced SWA levels in NREM sleep and a 24% lower surge of SFA at NREM-
REM sleep transitions compared to WT mice (Fig. 6). During SD-induced wakefulness,
Adk-tg mice showed a larger increase of SFA and a smaller increase of SWA (Fig. 7).
Adenosine A1 receptors, which are predominantly expressed in the cortex and in several
thalamic nuclei, including the thalamic reticular nucleus (Rosin et al., 1998; Ochiishi et al.,
1999), may mediate these genotype differences. Robust, but opposing pre- and postsynaptic
effects of adenosine via A1 receptors on thalamocortical oscillations were reported in ex-
vivo thalamic slices (Pape, 1992; Ulrich and Huguenard, 1995; Fontanez and Porter, 2006).
Our results are in agreement with a potent role of adenosine in mediating the
hyperpolarization of thalamocortical neurons, which de-inactivates the low-threshold
calcium channels in thalamic relay nuclei underlying the occurrence of slow waves
(reviewed in McCormick, 1992). The reduced adenosinergic tone in Adk-tg mice (Fedele et
al., 2005) may also alter ATP-regulated phosphorylation of T-type Ca2+ channels (Leresche
et al., 2004). In addition, adenosine modulates the release of several neurotransmitters
(Fredholm et al., 2005), including cholinergic, monoaminergic and histaminergic inputs to
the thalamocortical network which, thereby, may alter the firing pattern of thalamocortical
neurons.
The waking EEG is affected by Adk over-expression
Both the amount and quality of wakefulness were affected by ADK over-expression (Table
1). Adk-tg mice were more active during their waking bouts compared to WT mice (Fig. 4),
confirming previous results (Fedele et al., 2005;Yee et al., 2007). These findings mimic the
stimulant properties of the adenosine receptor antagonist caffeine (Schwierin et al.,
1996;Fredholm et al., 2005;Huang et al., 2005). It is likely that the increase in wakefulness
and corresponding reduction in sleep in Adk-tg mice is a consequence of reduced
adenosinergic tone throughout the brain, leading to increased activity of the ascending
monoaminergic system on the thalamus.
It is well-established from human and animal studies that EEG power in the low frequencies
increases in the course of prolonged wakefulness (e.g. Torsvall and Akerstedt, 1987;
Franken et al., 1993; Cajochen et al., 1995; Aeschbach et al., 1999; e.g. Achermann and
Borbely, 2003; Vyazovskiy and Tobler, 2005). We found a robust increase in EEG power of
frequencies below 8 Hz in both genotypes in the course of SD. Interestingly, initial levels
and rise rates of power in specific frequencies were different in Adk-tg mice (Fig. 7). These
differences may result from the behavioral alterations mentioned above. The mechanisms
underlying these alterations remain unclear.
Role of Adk in REM sleep
Strikingly, Adk-tg mice showed an overall reduction of REM sleep (Table 1). Several lines
of evidence support a role of the adenosinergic system in the onset and maintenance of REM
sleep. Microinjections of the A1 receptor agonist cyclopentyladenosine in the pontine
reticular formation, region implicated in the modulation of REM sleep (Monti and Monti,
2000), enhanced REM sleep duration in rats (Marks and Birabil, 2000;Marks et al., 2003).
This effect was counteracted by pretreatment with the adenosine receptor antagonist
cyclopentyltheophylline (Marks and Birabil, 1998). Consistently, microinjections of an A2A
receptor agonist in the same region also enhanced REM sleep and increased acetylcholine
release in rodents (Marks et al., 2003;Coleman et al., 2006). Initiation of REM sleep may be
deficient in Adk-tg mice due to alterations in glutamatergic excitation and GABAergic
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inhibition of REM sleep active neurons in the sublaterodorsal nucleus (Luppi et al., 2006).
Once REM sleep is initiated, it is maintained normally as indicated by the similar duration
of REM sleep episodes in WT and Adk-tg mice. Under increased sleep pressure the REM
sleep rebound was similar in the two genotypes, indicating that basic REM sleep regulatory
mechanisms are intact in Adk-tg mice.
In the present study, reduced theta activity after transitions to REM sleep in Adk-tg mice
implicates a role for adenosine in the modulation of theta oscillations. Moreover, theta peak
frequency in REM sleep was significantly lower in Adk-tg mice compared to WT mice,
while waking theta peak frequency was similar in the two genotypes (p = 0.18, unpaired t-
test). Changes in adenosinergic tone due to ADK over-expression may modulate the
frequency and amplitude of theta oscillations during REM sleep by changing the excitatory
input from the brainstem reticular formation to the septum (Vinogradova, 1995).
Conclusions
Our data suggest that ADK over-expression profoundly alters the sleep phenotype, likely by
lowering adenosine tone in the brain. It is tempting to speculate that ADK, by controlling
adenosine levels and its receptor mediated effects, may tune and integrate other
neurotransmitter pathways involved in sleep-wake regulation and the generation of related
EEG oscillations. Overall, our results are in accordance with a global rather than a region-
specific role of adenosine in sleep regulation (Heller, 2006).
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Figure 1.
EEG power density in microvolt square per Hertz (0.75–25 Hz) in NREM sleep, REM sleep
and waking in wild-type (WT; black dots; n = 14) and Adk-tg mice (white dots; n = 11)
during the 24-h baseline. Mean values of the parietal (PAR) and frontal (FRO) EEG.
Triangles: genotype differences (p < 0.05 for NREMS PAR and waking, p < 0.01 for
NREMS FRO and REMS; Bonferroni adjustment for multiple comparisons).
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Figure 2.
Representative 5-s raw parietal EEG and EMG traces during NREM sleep, REM sleep and
waking in wild-type (WT), Adk+/− and Adk-tg mice.
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Figure 3.
Time course of the vigilance states NREM sleep, REM sleep, waking and REM sleep as
percentage of total sleep time (REMS/TST) in WT and Adk-tg mice during the 24-h baseline
(BL; left panels) and 18-h recovery (Rec.; right panels) after 6 h sleep deprivation (SD; grey
area). Mean 2-h values. Triangles: genotype differences (p < 0.05, unpaired t-test; ANOVA
`genotype' × repeated `2-h interval': NREMS BL F(11,253) = 5.67, p < 0.0001 and Rec.
F(8,184) = 2.14, p = 0.034; REMS BL F(11,253) = 2.54, p = 0.0046 and Rec. F(8,184) = 1.81, p
= 0.078, `genotype' F(1,23) = 26.82, p < 0.0001 followed by Tukey-Kramer `genotype' p <
0.0001; REMS/TST BL F(11,253) = 1.14, p = 0.33, `genotype' F(1,23) = 20.96, p = 0.0001
followed by Tukey-Kramer `genotype' p < 0.0001 and Rec. F(8,184) = 2.04, p = 0.0437;
waking BL F(11,253) = 5.25, p < 0.0001 and Rec. F(8,184) = 1.91, p = 0.06).
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Figure 4.
Left: Number of NREM sleep episodes in WT (n = 14) and Adk-tg mice (n = 11) during the
24-h baseline. Mean values are expressed as percentage of the total number of NREM sleep
episodes. Numbers below the x-axis are duration range in seconds. Triangles: genotype
differences (p < 0.005, Tukey-Kramer; ANOVA `genotype' × `episode duration' F(1,7) =
14.02, p < 0.0001). Right: Activity intensity (defined as infra-red counts/number of 1-min
epochs with counts > 0; mean 1-h values; average of 10 consecutive baseline days) in WT (n
= 11) and Adk-tg mice (n = 12). Triangles: genotype differences (p < 0.05, unpaired t-test;
ANOVA `genotype' × repeated `1-h interval' F(23,483) = 4.32, p < 0.0001).
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Figure 5.
A: Time course of slow-wave activity (SWA) in NREM sleep in the parietal (PAR) and
frontal (FRO) EEG in WT and Adk-tg mice during 18-h recovery after 6 h SD (grey area).
Mean 2-h values are expressed as percentage of the mean 24-h baseline SWA in NREM
sleep of the corresponding EEG. Genotype differences (p < 0.001, Tukey-Kramer; ANOVA
`genotype' F(1,24) = 29.04, p < 0.0001 for PAR and F(1,24) = 14.23, p < 0.0009 for FRO;
interaction `genotype' × `2-h interval' F(8,183) = 1.06, p = 0.39 for PAR and F(8,183) = 1.55, p
= 0.14 for FRO). Differences from corresponding baseline interval in Adk-tg (open squares
below the curves, p < 0.05, paired t-test; ANOVA `condition' × `2-h interval' F(8,180) =
32.81 and 46.08, p < 0.0001 for PAR and FRO, respectively) and WT mice (filled squares, p
< 0.0001, paired t-test; F(8,234) = 48.32 and 46.76, p < 0.0001 for PAR and FRO). B: Time
course of SWA during the 2 min before and after transitions from waking to NREM sleep.
Mean 20-sec values computed for the first 6-h interval after SD and the corresponding
baseline interval are expressed as percentage of the mean 24-h baseline SWA in NREM
sleep. Triangles: genotype differences during recovery (p < 0.05, unpaired t-test; ANOVA
`genotype' × `20-sec epoch': F(11,252) = 2.01, p = 0.0276 for PAR and F(11,252) = 2.73, p =
0.0024 for FRO).
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Figure 6.
Time course of specific frequency bands during the 2 min before and after transitions from
NREM to REM sleep in WT and Adk-tg mice. Spindle frequency activity (SFA; 10.25–15
Hz) in the frontal EEG (left panel) and theta frequency activity (7.25–11 Hz) in the parietal
EEG (right panel). Mean 20-sec values for the 24-h baseline are expressed as percentage of
the mean 24-h baseline SFA or theta activity in NREM sleep. Triangles: genotype
differences (SFA, p < 0.0005, unpaired t-test; ANOVA `genotype' × `20-sec epoch': F(11,252)
= 10.64 and 41.49, p < 0.0001 for SFA and theta activity, respectively).
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Figure 7.
Time course of EEG power in waking in three frequency bands in the parietal EEG of WT
and Adk-tg mice during the 6 h SD (grey area) and first 6-h recovery. Mean 2-h values are
expressed as percentage of the mean 24-h baseline power in the corresponding frequency
band in waking. Triangles: genotype differences (p < 0.05, unpaired t-test; ANOVA
`genotype' × `2-h interval' F(5,114) = 2.46, p = 0.037 for 2.25–3.5 Hz band, F(5,114) = 15.67
and 6.95, p < 0.0001 for 6.25–9 Hz and 11.25–15 Hz band, respectively); asterisks:
difference between the first and last 2 h SD interval (p < 0.05, paired t-test).
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Figure 8.
Time course of NREM sleep (NREMS), REM sleep (REMS) and slow-wave activity (SWA;
EEG power between 0.75–4 Hz) in NREM sleep in the parietal (PAR) and frontal (FRO)
EEG in WT (black dots; n = 14) and Adk+/− mice (white dots; n = 15) during the 24-h
baseline. White and black bars indicate the 12-h light and dark period. Data represent 2-h
means; SWA is expressed as percentage of the 24-h mean SWA in NREM sleep.
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Figure 9.
Top: Western blot of ADK protein levels from the right hemisphere of adult WT, Adk+/−
and Adk-tg mice (numbers 1–6 correspond to individual mice). Bottom: Corresponding
quantitative analysis of the ADK levels of n = 6 mice per genotype (O.D. = optical density).
ADK was first normalized to equal loading according to the α-Tubulin standard and then to
the ADK level of WT mice (=100%). Differences from WT: **p < 0.001, unpaired t-test.
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Table 2
Frequency and duration of vigilance state episodes
WT (n = 14) Adk-tg (n = 11)
Frequency Duration (min) Frequency Duration (min)
NREMS 569.1 ± 21.3 1.32 ± 0.06 382.8 ± 17.1** 1.88 ± 0.09**
REMS 123.0 ± 5.8 1.06 ± 0.04 96.9 ± 4.5* 1.06 ± 0.02
Waking 566.2 ± 20.9 1.03 ± 0.04 381.9 ± 17.5** 1.69 ± 0.09**
Mean frequency and duration of NREM sleep (NREMS), REM sleep (REMS) and waking episodes ± SEM in wild-type (WT) and Adk-tg mice
during the 24-h baseline. Genotype differences:
unpaired t-test.
*
p < 0.005,
**
p < 0.0005,
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